Lenvakast 10 mg (lenvatinib) is an anti-cancer medicine that is indicated specifically for renal cell carcinoma (RCC) and differentiated thyroid cancer. In kidney cancer everolimus is used in combination with 10 mg of lenvakast (lenvatinib) for sustained effectiveness. Meanwhile, lenvakast 10 mg (lenvatinib) is preferred for thyroid cancer if the cancer cannot be removed surgically.